Examkin

Soru

Zorluk: ZorDisposition and Care Setting Transitions

A 54-year-old woman presents to the emergency department after recording a temperature of 38.5°C (101.3°F) at home two hours ago. She has a history of stage II right breast cancer and underwent a lumpectomy six weeks ago. She is currently receiving adjuvant chemotherapy, with her most recent cycle of docetaxel and cyclophosphamide administered 8 days ago. The patient reports mild fatigue but denies chills, cough, shortness of breath, dysuria, abdominal pain, or diarrhea. She has no other significant medical conditions. She lives 10 miles from the hospital with her husband, who drove her to the emergency department today.

Temperature is 38.3°C (100.9°F), blood pressure is 122/78 mm Hg, pulse is 92/min, and respiratory rate is 16/min. Pulse oximetry is 99% on room air. The patient appears comfortable and in no acute distress. The implanted central venous catheter site is clean without erythema, induration, or tenderness. Cardiopulmonary examination is normal. The abdomen is soft and non-tender.

Laboratory studies show:
Leukocyte count: 1,100/µL
Absolute neutrophil count: 350/µL
Hemoglobin: 11.2 g/dL
Platelets: 145,000/µL
Blood urea nitrogen: 14 mg/dL
Serum creatinine: 0.8 mg/dL
Hepatic function panel: Normal

Chest radiograph shows no infiltrates. Urinalysis is unremarkable. The patient is able to tolerate oral fluids in the emergency department without nausea.

Which of the following is the most appropriate disposition for this patient?

  1. A
    Admit to the general medical ward for intravenous cefepime
  2. B
    Admit to a protective environment room for intravenous meropenem and vancomycin
  3. C
    Discharge to an outpatient infusion center for daily intravenous ceftriaxone
  4. Discharge to home with oral ciprofloxacin and amoxicillin-clavulanateCevap
  5. E
    Admit to the intensive care unit for continuous hemodynamic monitoring

Cevap

Discharge to home with oral ciprofloxacin and amoxicillin-clavulanate
The correct disposition is to discharge the patient home with oral antibiotics. This patient presents with febrile neutropenia, defined as a single oral temperature of ≥\geq 38.3°C (101°F) and an absolute neutrophil count (ANC) <500< 500/µL. While febrile neutropenia is an oncologic emergency, not all patients require inpatient admission. Risk stratification using validated tools, such as the Multinational Association for Supportive Care in Cancer (MASCC) risk index or the Clinical Index of Stable Febrile Neutropenia (CISNE), helps determine the appropriate care setting. This patient is considered low-risk because she has no significant medical comorbidities, is hemodynamically stable, lacks focal signs of infection (e.g., pneumonia, port infection), is able to tolerate oral intake, and has reliable social support and transportation. According to current guidelines, low-risk patients can be safely discharged home with oral empiric antibiotics. The standard outpatient regimen is a fluoroquinolone (e.g., ciprofloxacin or levofloxacin) plus amoxicillin-clavulanate to provide necessary broad-spectrum coverage, crucially including coverage against Pseudomonas aeruginosa.

Adım Adım Çözüm

1
Diagnose the acute condition based on vital signs and laboratory results.
The patient has febrile neutropenia, defined by a temperature ≥\geq 38.3°C and an absolute neutrophil count (ANC) <500< 500/µL.
Identifying febrile neutropenia is critical as it is an oncologic emergency requiring prompt empiric antibiotics.
2
Risk stratify the patient using clinical criteria (e.g., MASCC or CISNE score) to determine the risk of serious complications.
The patient is classified as low-risk.
She has a solid tumor, is hemodynamically stable, lacks medical comorbidities, has no focal site of infection, tolerates oral intake, and has reliable social support.
3
Determine the appropriate care setting and empiric antibiotic regimen for a low-risk patient.
Discharge home with an oral fluoroquinolone (e.g., ciprofloxacin) plus amoxicillin-clavulanate.
Low-risk patients do not require hospitalization and can be safely managed as outpatients with oral antibiotics that provide broad-spectrum coverage, specifically including Pseudomonas aeruginosa.

Anahtar Kavram

Patients with low-risk febrile neutropenia (solid tumor, hemodynamically stable, no comorbidities, tolerating PO, good social support) should be discharged home with empiric oral antibiotics (e.g., a fluoroquinolone plus amoxicillin-clavulanate) rather than being admitted for intravenous therapy.
Bu soruyu puanla

Konular

Disposition and Care Setting Transitions

Bu konudan daha fazla soru